CEO at CYBIN Inc. (NYSE:CYBN) | Healthcare Investor & Advisor | EY Entrepreneur of the Year | 2020 Inc. 5000 | TWTR @insidepharma
This was quite a track record of performance for Cybin over the past year: - Positive phase 2 safety and efficacy readout for CYB003 as an adjunctive treatment for MDD - Around 75% of MDD patients in remission after just two doses - sustained for at least 4 months - Breakthrough Therapy Designation awarded to CYB003 by FDA - Successful recruitment of 30 sites for an upcoming phase 3 study of CYB003 in MDD this summer - Closing and integration of the Small Pharma team, along with programs and IP - Acceleration of CYB004 IM formulation aimed at delivering a 90 minute experience - Initiation of a phase 2 study of CYB004 in GAD with top line results expected around year end 2024
#Cybin has evolved into a mature, late-stage company with critical milestones on the near-term horizon. With #FDA #BTD designation and positive four-month durability data for #CYB003 and the initiation of our Phase 2 study of #CYB004, we are rapidly advancing our mission to change the treatment paradigm for #MDD and #GAD and bring innovative treatment options to patients in need. —Cybin CEO Doug Drysdale Read our full release on fiscal year 2024 and recent business highlights: https://loom.ly/4r6Nng0 #MentalHealthInnovation #Biotechnology #Psychedelics
Amazing teamwork and a clear vision are essential drivers of these exciting programs
Very exciting and a lot of momentum for Cybin, like to see it.
"Around 75% of MDD patients in remission after just two doses - sustained for at least 4 months" This Is incredible, wishing the team sustained success for the rest of the year.
Success takes time, ESPECIALLY in the pharma space. Gotta get it right....& Cybin is doing that. Great management, great vision & a great, natural & effective product to address a massive mental health problem. U gotta love what's on the horizon!
Incredible progress and execution. Congratulations Doug Drysdale and Cybin Inc! I cannot wait to see results for CYB004 (awesome how the company is assessing durability of effects out to one year!). Keep up the amazing work.
Excellent progress Doug. Congratulations Damon
Wishing you the best
Fantastic, team Cybin Inc and Doug Drysdale! Keep up the amazing work!
I’m an investor and big believer. I plan to stay that way, congrats and keep going!
Director, Manufacturing Sciences @ Leadiant Biosciences, Inc. | Manufacturing Operations
6moWholeheartedly believe in and support what you're doing but your stock has been tanking for a while now. When will we here something other than "this Summer" re: Phase 3? Asking both as an investor and someone that could greatly benefit from the work you are doing.